FY2021 EPS Estimates for Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Lowered by Colliers Secur.

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) – Colliers Secur. cut their FY2021 earnings per share estimates for shares of Allscripts Healthcare Solutions in a research note issued to investors on Monday, October 26th. Colliers Secur. analyst G. Mannheimer now expects that the software maker will post earnings of $0.31 per share for the year, down from their previous forecast of $0.53.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last announced its earnings results on Thursday, October 29th. The software maker reported $0.20 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.19 by $0.01. Allscripts Healthcare Solutions had a positive return on equity of 5.55% and a negative net margin of 3.06%. The business had revenue of $402.00 million during the quarter, compared to analyst estimates of $419.75 million. During the same quarter in the previous year, the business earned $0.17 earnings per share. The company’s revenue for the quarter was down 9.7% compared to the same quarter last year.

Several other brokerages have also issued reports on MDRX. SVB Leerink boosted their target price on Allscripts Healthcare Solutions from $10.00 to $13.00 and gave the company a “market perform” rating in a research report on Wednesday, October 14th. Canaccord Genuity reaffirmed a “buy” rating on shares of Allscripts Healthcare Solutions in a research note on Friday, July 31st. Morgan Stanley lifted their price target on shares of Allscripts Healthcare Solutions from $6.00 to $8.00 and gave the company an “underweight” rating in a research note on Tuesday, August 11th. TheStreet raised shares of Allscripts Healthcare Solutions from a “d” rating to a “c-” rating in a research note on Friday, July 31st. Finally, Robert W. Baird downgraded shares of Allscripts Healthcare Solutions from an “outperform” rating to a “neutral” rating and set a $13.00 price target for the company. in a research note on Monday, October 19th. Six research analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average target price of $9.83.

Shares of NASDAQ:MDRX opened at $10.27 on Wednesday. Allscripts Healthcare Solutions has a 1 year low of $4.56 and a 1 year high of $11.82. The business has a 50 day simple moving average of $9.06 and a two-hundred day simple moving average of $7.70. The firm has a market capitalization of $1.67 billion, a PE ratio of -31.12, a price-to-earnings-growth ratio of 3.08 and a beta of 1.08. The company has a debt-to-equity ratio of 0.53, a current ratio of 0.78 and a quick ratio of 0.78.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Versant Capital Management Inc grew its holdings in Allscripts Healthcare Solutions by 11,786.5% in the second quarter. Versant Capital Management Inc now owns 4,398 shares of the software maker’s stock worth $29,000 after purchasing an additional 4,361 shares during the last quarter. Advisor Group Holdings Inc. purchased a new position in Allscripts Healthcare Solutions in the first quarter worth $34,000. Nisa Investment Advisors LLC grew its holdings in shares of Allscripts Healthcare Solutions by 199.6% during the third quarter. Nisa Investment Advisors LLC now owns 7,430 shares of the software maker’s stock valued at $60,000 after buying an additional 4,950 shares during the last quarter. Aigen Investment Management LP purchased a new stake in shares of Allscripts Healthcare Solutions during the second quarter valued at $68,000. Finally, PNC Financial Services Group Inc. grew its holdings in shares of Allscripts Healthcare Solutions by 147.7% during the second quarter. PNC Financial Services Group Inc. now owns 10,055 shares of the software maker’s stock valued at $68,000 after buying an additional 5,995 shares during the last quarter.

In other Allscripts Healthcare Solutions news, insider Lisa Khorey sold 15,000 shares of Allscripts Healthcare Solutions stock in a transaction on Wednesday, October 14th. The shares were sold at an average price of $11.04, for a total value of $165,600.00. Following the transaction, the insider now directly owns 270,889 shares of the company’s stock, valued at $2,990,614.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Paul Black sold 30,000 shares of Allscripts Healthcare Solutions stock in a transaction on Wednesday, October 14th. The stock was sold at an average price of $11.04, for a total transaction of $331,200.00. The disclosure for this sale can be found here. Insiders own 1.42% of the company’s stock.

Allscripts Healthcare Solutions Company Profile

Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Featured Story: How to interpret Moving Average Convergence Divergence (MACD)

Earnings History and Estimates for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.